Abstract | PURPOSE: RESULTS:
D-Norgestrel and DHT activated the AR pathway, while 17β-Estradiol did not. Competitive binding for AR protein showed similar affinity between DHT and D-Norgestrel, indicating direct AR- ligand interaction. In vivo production of hK2 was sufficient to achieve site-specific delivery of therapeutic radionuclide to tumor tissue at >20-fold over background muscle uptake; effecting long-term local tumor control. CONCLUSIONS:
|
Authors | Daniel L J Thorek, Anson T Ku, Nicholas Mitsiades, Darren Veach, Philip A Watson, Dipti Metha, Sven-Erik Strand, Sai Kiran Sharma, Jason S Lewis, Diane S Abou, Hans G Lilja, Steven M Larson, Michael R McDevitt, David Ulmert |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 25
Issue 2
Pg. 881-891
(01 15 2019)
ISSN: 1557-3265 [Electronic] United States |
PMID | 30254080
(Publication Type: Journal Article)
|
Copyright | ©2018 American Association for Cancer Research. |
Chemical References |
- Biomarkers, Tumor
- Immunoconjugates
- Receptors, Androgen
- HK2 protein, human
- Hexokinase
|
Topics |
- Alpha Particles
(therapeutic use)
- Animals
- Biomarkers, Tumor
- Breast Neoplasms
(metabolism, mortality, pathology, therapy)
- Cell Line, Tumor
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Female
- Hexokinase
(antagonists & inhibitors)
- Humans
- Immunoconjugates
(administration & dosage, pharmacokinetics)
- Mice
- Molecular Targeted Therapy
- Radioimmunotherapy
- Radiometry
- Receptors, Androgen
(metabolism)
- Signal Transduction
(drug effects, radiation effects)
- Tissue Distribution
- Xenograft Model Antitumor Assays
|